- Home
- FMBH vs OCS Comparison
FMBH vs OCS Comparison
Compare FMBH & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMBH
- OCS
- Stock Information
- Founded
- FMBH 1865
- OCS 2003
- Country
- FMBH United States
- OCS Switzerland
- Employees
- FMBH N/A
- OCS N/A
- Industry
- FMBH Major Banks
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- FMBH Finance
- OCS Health Care
- Exchange
- FMBH Nasdaq
- OCS Nasdaq
- Market Cap
- FMBH 974.1M
- OCS 956.4M
- IPO Year
- FMBH N/A
- OCS N/A
- Fundamental
- Price
- FMBH $39.67
- OCS $16.94
- Analyst Decision
- FMBH Hold
- OCS Strong Buy
- Analyst Count
- FMBH 5
- OCS 4
- Target Price
- FMBH $43.40
- OCS $35.75
- AVG Volume (30 Days)
- FMBH 65.8K
- OCS 13.4K
- Earning Date
- FMBH 10-30-2025
- OCS 11-06-2025
- Dividend Yield
- FMBH 2.51%
- OCS N/A
- EPS Growth
- FMBH 13.11
- OCS N/A
- EPS
- FMBH 3.52
- OCS N/A
- Revenue
- FMBH $328,480,000.00
- OCS $960,668.00
- Revenue This Year
- FMBH N/A
- OCS $11.49
- Revenue Next Year
- FMBH $4.33
- OCS $1,784.02
- P/E Ratio
- FMBH $11.31
- OCS N/A
- Revenue Growth
- FMBH 7.81
- OCS N/A
- 52 Week Low
- FMBH $27.58
- OCS $11.78
- 52 Week High
- FMBH $43.86
- OCS $23.08
- Technical
- Relative Strength Index (RSI)
- FMBH 51.72
- OCS 41.97
- Support Level
- FMBH $39.63
- OCS $16.00
- Resistance Level
- FMBH $40.21
- OCS $17.35
- Average True Range (ATR)
- FMBH 0.73
- OCS 0.39
- MACD
- FMBH -0.08
- OCS 0.05
- Stochastic Oscillator
- FMBH 12.44
- OCS 44.76
About FMBH First Mid Bancshares Inc.
First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The Company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.